Vanguard Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
Other funds holding ORIC
SL
Vanguard Capital Management's ORIC Position: Q3 2026 in Review
Vanguard Capital Management increased its Oric Pharmaceuticals (ORIC) stake by 3.1% in Q3 2026, buying an estimated $1.51M and bringing the position to 4,072,661 shares worth $54.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1841.
Vanguard Capital Management first reported a position in ORIC in Q1 2026 and has held it in 3 quarters since. 203 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.
- Vanguard Capital Management held 4,072,661 shares of Oric Pharmaceuticals worth $54.9M as of Q3 2026.
- Vanguard Capital Management bought 121,492 Oric Pharmaceuticals shares in Q3 2026, an estimated $1.51M.
- Oric Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1841 holding.
- Vanguard Capital Management first reported a position in Oric Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
- 203 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.